BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 6, 2002
View Archived Issues
Waksal Subpoenaed; ImClone To Face House Subcommittee
WASHINGTON - Former ImClone Systems Inc. CEO Samuel Waksal has been subpoenaed by a House subcommittee to answer questions surrounding the business transactions and development of the investigational cancer drug Erbitux. (BioWorld Today)
Read More
Battered' Market Prompts LSB To Reduce Staff, Shift Resources
Read More
Lab-Grown Cholera Bacteria No Match For Natural Stool Germs, In In Vivo-In Silico Competition
Read More
LION Plans To Narrow Focus, Unload Drug Discovery Unit
Read More
TransForm, ALZA Sign Deal For Transdermal Products
Read More
Other News To Note
Read More